DSGN Stock Analysis: Buy, Sell, or Hold?
DSGN - Design Therapeutics, Inc. Common Stock
$10.21
-0.36 (-3.41%)
▼
5d:
+0.29%
30d:
+4.29%
90d:
+57.32%
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 09, 2026
Get Alerted When DSGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DSGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DSGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DSGN is currently trading at $10.21, which is considered extended relative to its 30-day fair value range of $9.12 to $10.02.
Technical Outlook: Technically, DSGN is in a strong uptrend. Immediate support is located at $9.04, while resistance sits at $10.97. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: DSGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.40 (+41.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DSGN is in a strong uptrend. Immediate support is located at $9.04, while resistance sits at $10.97. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: DSGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.40 (+41.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$9.12 -
$10.02
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 41.0% below Wall St target ($14.40)
Fair Price Analysis
30-Day Fair Range
$9.12 -
$10.02
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$9.04
Resistance Level
$10.97
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-7.88
Wall Street Target
$14.40
(+41.0%)
Last updated: February 01, 2026 9:29 PM ET
Data refreshes hourly during market hours. Next update: 10:29 PM
Data refreshes hourly during market hours. Next update: 10:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DSGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$847 | 52 HOLD |
